Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - OTHER CURRENT LIABILITIES
Other Current Liabilities REPL - Replimune Group, Inc.
30.1 M
LAST VALUE
75.62%
2 YEAR CAGR
60.79%
5 YEAR CAGR
0.00%
10 YEAR CAGR